Kestra Advisory Services, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 503 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Kestra Advisory Services, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2024$870,317
-18.7%
16,114
+2.6%
0.01%
-28.6%
Q1 2024$1,070,589
+50.1%
15,707
+37.8%
0.01%
+16.7%
Q4 2023$713,452
+179.3%
11,397
+102.5%
0.01%
+100.0%
Q3 2023$255,455
-25.4%
5,628
-7.7%
0.00%0.0%
Q2 2023$342,286
+26.0%
6,097
+1.5%
0.00%0.0%
Q1 2023$271,606
+6.4%
6,005
-4.4%
0.00%
+50.0%
Q4 2022$255,323
-99.9%
6,281
-53.4%
0.00%
-60.0%
Q3 2022$440,440,000
+106030.1%
13,476
+97.1%
0.01%
+25.0%
Q2 2022$415,000
+22.1%
6,837
+26.4%
0.00%0.0%
Q1 2022$340,000
+4.3%
5,410
+25.6%
0.00%
+33.3%
Q4 2021$326,000
-76.6%
4,308
-65.5%
0.00%
-78.6%
Q3 2021$1,396,000
-29.3%
12,472
+2.2%
0.01%
-36.4%
Q2 2021$1,975,000
+170.9%
12,200
+104.0%
0.02%
+144.4%
Q1 2021$729,000
-58.0%
5,981
-44.3%
0.01%
-55.0%
Q4 2020$1,735,00010,7370.02%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$37,781,00020.21%
Ariose Capital Management Ltd 37,900$2,872,0006.78%
EcoR1 Capital, LLC 1,077,483$81,652,0002.60%
NEA Management Company, LLC 1,590,002$120,490,0002.44%
ARK Investment Management 9,087,868$688,679,0002.08%
NIA IMPACT ADVISORS, LLC 62,609$3,876,0002.06%
Deuterium Capital Management, LLC 18,000$1,364,0002.02%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,200$8,192,0001.82%
PLUSTICK MANAGEMENT LLC 50,000$3,789,0001.76%
Nikko Asset Management Americas, Inc. 4,319,471$330,526,0001.74%
View complete list of CRISPR THERAPEUTICS AG shareholders